v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash Flows from Operating Activities:    
Net Loss $ (3,712,941) $ (3,511,254)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 10,250 10,043
Stock compensation expense 141,887 62,250
Loss on deconsolidation of Shuya 145,677
Amortization of debt discount 1,398,686 133,053
Change in fair value of derivative liabilities (924,589)
Change in FV of warrant liability 378
Attributable income per equity method - Shuya (38,089) (57,980)
Reversal of inventory impairment reserve (357,639)
(Increase) decrease in right of use asset (183,179) 37,591
(Increase) decrease in lease liability 179,551 (35,289)
(Increase) decrease in accounts receivable (99,241) (9,228)
(Increase) decrease in accounts receivable – related party (409,698) (548,106)
(Increase)/ decrease in Tax receivable (43,639)
(Increase) decrease in prepaid expenses (36,162) 491,500
(Increase) decrease in contract asset (43,112) (39,415)
(Increase) decrease in other assets (2,967,071) 111,952
(Increase) decrease in inventory 337,975 (231,760)
(Decrease) increase in accounts payable 181,685 540,614
(Decrease) increase in accrued interest 266,967 133,756
Other (Decrease) increase in accrued expenses (53,525) 145,116
Other (Decrease) increase in customer deposits 176,642 (123,489)
Net Cash Used In Operating Activities (6,131,225) (2,788,608)
Cash Flows from Investing Activities    
Purchase of fixed assets (12,624)
Loan receivables 83,340
Cash Flows Provided By (Used In) Investing Activities (12,624) 83,340
Cash Flows from Financing Activities    
Proceeds from notes payable and lines of credit 3,867,950 1,425,520
Borrowing from related party 691,392
Other receivable (156,243)
Loan to Rongjun (104,227)
Payments on notes payable and line of credit (1,816,190) (644,257)
Stock issued for cash 4,399,999 1,983,000
Cash Flows Provided By Financing Activities 6,986,908 2,660,036
Foreign Currency Transaction (78,374) (244)
Net (Decrease) Increase in Cash and Cash Equivalents 764,685 (45,476)
Cash and Cash Equivalents at Beginning of Period 62,101 89,625
Cash and Cash Equivalents at End of Period 826,786 44,149
Supplemental Cashflow Information:    
Interest Paid 171,929 99,214
Supplemental Non-Cash Disclosure    
Discount on new notes 683,311
Shares issued for preferred conversions 2,115
Dividend accrued 42,751 108,842
Shares issued for accrued dividend 48,038
Shares issued for note conversion $ 2,658,691